Sociodemographic characteristics and clinical risk factors of Helicobacter pylori infection and antibiotic resistance in the Eastern Black Sea region of Turkey

Öz:

Background/Aims: The aim of this study was to assess the clinical and sociodemographic risk factors of Helicobacter pylori infectionand antibiotic resistance in the eastern Black Sea region of Turkey.Materials and Methods: In total, 344 patients with dyspeptic symptoms who completed an extended questionnaire were enrolled in thestudy. Diagnosis of H. pylori infection was made by rapid urease test, histopathological investigation, and culture. Susceptibility of H.pylori strains was assessed by agar dilution (amoxicillin, tetracycline, metronidazole, levofloxacin) and E-test (clarithromycin) methods.Results: The H. pylori positivity rate was 40.4% (139/344). Logistic regression analysis indicated that age and the presence of duodenalulcer were independent risk factors associated with H. pylori positivity (odds ratio (OR): 0.96, 95% CI: 0.93–0.99, p=0.013; OR: 5.42, 95%CI: 1.96–14.98, p=0.001, respectively). Of 104 H. pylori-positive cultures, 43 strains (41%) were susceptible to all antibiotics, whereas 61(59%) were resistant to at least one antibiotic. H. pylori resistance rates were 34% for levofloxacin, 31.1% for metronidazole, 28.2% forclarithromycin, 2.9% for amoxicillin, and 1% for tetracycline. Logistic regression analysis indicated that previous use of clarithromycinwas the only independent risk factor for H. pylori resistance (OR: 6.25, 95% CI: 1.59-24.52, p=0.009).Conclusion: An understanding of the risk factors for H. pylori positivity and antibiotic resistance in an extended anamnesis may affecttreatment choice and facilitate H. pylori eradication. In regions where antibiotic resistance rates are elevated, performing antibioticsusceptibility tests may lead to effective eradication treatment.

Anahtar Kelime:

Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık

1. Chey WD, Wong BC; Practice Parameters Committee of the American College of Gastroenterology. American College of Gastroenterology guideline on the management of Helicobacter pylori infection. Am J Gastroenterol 2007; 102: 1808-25. [Crossref]
2. Hunt RH, Xiao SD, Megraud F, et al. World Gastroenterology Organisation Global Guideline: Helicobacter pylori in developing countries. J Dig Dis 2011; 12: 319-26. [Crossref]
3. Brown LM, Thomas TL, Ma JL, et al. Helicobacter pylori infection in rural China: demographic, lifestyle and environmental factors. Int J Epidemiol 2002; 31: 638-45. [Crossref]
4. Sinha SK, Martin B, Sargent M, McConnell JP, Bernstein CN. Age at acquisition of Helicobacter pylori in a pediatric Canadian First Nations population. Helicobacter 2002; 7: 76-85. [Crossref]
5. Malfertheiner P, Megraud F, O’Morain CA, et al; European Helicobacter and Microbiota Study Group and Consensus panel. Management of Helicobacter pylori infection the Maastricht V/Florence Consensus Report. Gut 2017; 66: 6-30. [Crossref]
6. Kearney DJ, Brousal A. Treatment of Helicobacter pylori infection in clinical practice in the United States: results from 224 patients. Dig Dis Sci 2000; 45: 265-71. [Crossref]
7. Kadayifci A, Buyukhatipoglu H, Cemil Savas M, Simsek I. Eradication of Helicobacter pylori with triple therapy: an epidemiologic analysis of trends in Turkey over 10 years. Clin Ther 2006; 28: 1960- 6. [Crossref]
8. Gisbert JP. “Rescue” regimens after Helicobacter pylori treatment failure. World J Gastroenterol 2008; 14: 5385-402. [Crossref]
9. O’Connor A, Gisbert J, O’Morain C. Treatment of Helicobacter pylori infection. Helicobacter 2009; 14: 46-51. [Crossref]
10. Boyanova L, Ilieva J, Gergova G, et al. Evaluation of clinical and socio-demographic risk factors for antibacterial resistance of Helicobacter pylori in Bulgaria. J Med Microbiol 2009; 58: 94-100. [Crossref]
11. Megraud FH. pylori antibiotic resistance: prevalence, importance, and advances in testing. Gut 2004; 53: 1374-84. [Crossref]
12. Osato, MS, Reddy R, Reddy SG, Penland, RL, Malaty HM, Graham, DY. Pattern of primary resistance of Helicobacter pylori to metronidazole or clarithromycin in the United States. Arch Intern Med 2001; 161: 1217-20. [Crossref]
13. McMahon BJ, Hennessy TW, Bensler, JM, et al. The relationship among previous antimicrobial use, antimicrobial resistance, and treatment outcomes for Helicobacter pylori infections. Ann Intern Med 2003; 139: 463-9. [Crossref]
14. Boyanova L, Ilieva J, Gergova G, et al. Numerous risk factors for Helicobacter pylori antibiotic resistance revealed by extended anamnesis: a Bulgarian study. J Med Microbiol 2012; 61: 85-93. [Crossref]
15. Boyanova L, Mitov I. Geographic map and evolution of primary Helicobacter pylori resistance to antibacterial agents. Expert Rev Anti Infect Ther 2010; 8: 59-70. [Crossref]
16. Goh KL, Chan WK, Shiota S, Yamaoka Y. Epidemiology of Helicobacter pylori infection and public health implications. Helicobacter 2011; 16: 1-9. [Crossref]
17. Best LM, Haldane DJ, Keelan M, et al. Multilaboratory Comparison of Proficiencies in Susceptibility Testing of Helicobacter pylori and Correlation between Agar Dilution and E Test Methods. Antimicrob Agents Chemother 2003; 47: 3138-44. [Crossref]
18. Mégraud F, Lehours P. Helicobacter pylori detection and antimicrobial susceptibility testing. Clin Microbiol Rev 2007; 20: 280-322. [Crossref]
19. Glupczynski Y, Mégraud F, Lopez-Brea M, Andersen LP. European multicentre survey of in vitro antimicrobial resistance in Helicobacter pylori. Eur J Clin Microbiol Infect Dis 2001; 20: 820-3. [Crossref]
20. Tonkic A, Tonkic M, Lehours P, Mégraud F. Epidemiology and diagnosis of Helicobacter pylori infection. Helicobacter 2012; 17 :1-8. [Crossref]
21. Ozdil K, Sahin A, Kahraman R, Yuzbasioglu B, Demirdag H, Calhan T et al. Current prevalence of intestinal metaplasia and Helicobacter pylori infection in dyspeptic adult patients from Turkey. Hepatogastroenterology 2010; 57: 1563-6.
22. McColl KE. Clinical practice: Helicobacter pylori infection. N Engl J Med 2010; 362: 1597-604. [Crossref]
23. Lai LH, Sung JJ. Helicobacter pylori and benign upper digestive disease. World J Gastroenterol 2014; 20: 5903-11.
24. Kong YJ, Yi HG, Dai JC, Wei MX. Histological changes of gastric mucosa after Helicobacter pylori eradication: a systematic reviewand meta-analysis. Best Pract Res Clin Gastroenterol 2007; 21: 261-79.
25. Agarwal PK, Badkur M, Agarwal R, Patel S. Prevalence of Helicobacter pylori infection in upper gastrointestinal tract disorders (dyspepsia) patients visiting outpatient department of a hospital of North India. J Family Med Prim Care 2018; 7: 577-80. [Crossref]
26. Shi R, Xu S, Zhang H, et al. Prevalence and risk factors for Helicobacter pylori infection in Chinese populations. Helicobacter 2008; 13: 157-65. [Crossref]
27. Zhang L, Eslick GD, Xia HH, Wu C, Phung N, Talley NJ. Relationship between alcohol consumption and active Helicobacter pylori infection. Alcohol Alcohol 2010; 45: 89-94. [Crossref]
28. Kim MS, Kim N, Kim SE, et al. Long-term Follow-up Helicobacter Pylori Reinfection Rate and Its Associated Factors in Korea. Helicobacter 2013; 18: 135-42. [Crossref]
29. Gao L, Weck MN, Stegmaier C, Rothenbacher D, Brenner H. Alcohol consumption, serum gamma-glutamyltransferase, and helicobacter pylori infection in a population-based study among 9733 older adults. Ann Epidemiol 2010; 20: 122-8. [Crossref]
30. Guo Z, Li Y, Xu Z, Ji F, Wang L, Chen K. A case-control study on risk factors of helicobacter pylori infection in out-patients with stomach diseases. Zhonghua Yu Fang Yi Xue Za Zhi 2002; 36: 187-90.
31. Boyanova L, Ilieva J, Gergova G, Vladimirov B, Nikolov R, Mitov I. Honey and green/black tea consumption may reduce the risk of Helicobacter pylori infection. Diagn Microbiol Infect Dis 2015; 82: 85-6. [Crossref]
32. Zou QH, Li RQ. Helicobacter pylori in the oral cavity and gastric mucosa: a meta-analysis. J Oral Pathol Med 2011; 40: 317-24. [Crossref]
33. Jia CL, Jiang GS, Li CH, Li CR. Effect of dental plaque control on infection of Helicobacter pylori in gastric mucosa. Tex Dent J 2012; 129: 1069-73.
34. Dattoli VC, Veiga RV, da Cunha SS, Pontes-de-Carvalho LC, Barreto ML, Alcantara-Neves NM. Seroprevalence and potential risk factors for Helicobacter pylori infection in Brazilian children. Helicobacter 2010; 15: 273-8. [Crossref]
35. Fialho AM, Braga AB, Braga Neto MB, et al. Younger siblings play a major role in Helicobacter pylori transmission among children from a lowincome community in the Northeast of Brazil. Helicobacter 2010; 15: 491-6. [Crossref]
36. Ahmed KS, Khan AA, Ahmed I, et al. Impact of household hygiene and water source on the prevalence and transmission of Helicobacter pylori: a South Indian perspective. Singapore Med J 2007; 48: 543-9.
37. Nouraie M, Latifi-Navid S, Rezvan H, et al. Childhood hygienic practice and family education status determine the prevalence of Helicobacter pylori infection in Iran. Helicobacter 2009; 14: 40-6. [Crossref]
38. Graham DY, Malaty HM, Evans DG, Evans DJ Jr, Klein PD, Adam E. Epidemiology of Helicobacter pylori in an asymptomatic population in the United States. Effect of age, race, and socioeconomic status. Gastroenterology 1991; 100: 1495-501. [Crossref]
39. Kuo YT, Liou JM, El-Omar EM, et al; Asian Pacific Alliance on Helicobacter and Microbiota. Primary antibiotic resistance in Helicobacter pylori in the Asia-Pacific region: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol 2017; 2: 707-15. [Crossref]
40. Kocazeybek B, Tokman HB. Prevalence of Primary Antimicrobial Resistance of H. pylori in Turkey: A Systematic Review. Helicobacter 2016; 21: 251-60. [Crossref]
41. Caliskan R, Tokman HB, Erzin Y, et al. Antimicrobial resistance of Helicobacter pylori strains to five antibiotics, including levofloxacin, in Northwestern Turkey. Rev Soc Bras Med Trop 2015; 48: 278-84.
42. Boyanova L, Gergova G, Nikolov R, Davidkov L, Kamburov V, Jelev C, et al. Prevalence and evolution of Helicobacter pylori resistance to 6 antibacterial agents over 12 years and correlation between susceptibility testing methods. Diagn Microbiol Infect Dis 2008; 60: 409-15. [Crossref]
43. Zullo A, Perna F, Hassan C, et al. Primary antibiotic resistance in Helicobacter pylori strains isolated in northern and central Italy. Aliment Pharmacol Ther 2007; 25: 1429-34. [Crossref]
44. Koivisto TT, Rautelin HI, Voutilainen ME, et al. Primary Helicobacter pylori resistance to metronidazole and clarithromycin in the Finnish population. Aliment Pharmacol Ther 2004; 19: 1009-17. [Crossref]
45. O’Connor A, Taneike I, Nami A, et al. Helicobacter pylori resistance to metronidazole and clarithromycin in Ireland. Eur J Gastroenterol Hepatol 2010; 22: 1123-27. [Crossref]
46. Kostamo P, Veijola L, Oksanen A, Sarna S, Rautelin H. Recent trends in primary antimicrobial resistance of Helicobacter pylori in Finland. Int J Antimicrob Agents 2011; 37: 22-5. [Crossref]
47. Ojetti V, Migneco A, Silveri N, Ghirlanda G, Gasbarrini G, Gasbarrini A. The role of H. Pylori infection in diabetes. Curr Diabetes Rev 2005; 1: 343-7. [Crossref]
48. Demir M, Gokturk HS, Ozturk NA, Arslan H, Serin E, Yilmaz U. Clarithromycin resistance and efficacy of clarithromycin-containing triple eradication therapy for Helicobacter pylori infection in type 2 diabetes mellitus patients. South Med J 2009; 102: 1116-20. [Crossref]

APA	erkut m, UZUN D, KAKLIKKAYA N, FİDAN S, YOĞUN Y, COŞAR A, AKYILDIZ E, Topbas M, ozgur o, Arslan M (2020). Sociodemographic characteristics and clinical risk factors of Helicobacter pylori infection and antibiotic resistance in the Eastern Black Sea region of Turkey. , 221 - 233. 10.5152/tjg.2020.18631
Chicago	erkut murat,UZUN Doğan Yusuf,KAKLIKKAYA NESE,FİDAN Sami,YOĞUN Yaşar,COŞAR Arif Mansur,AKYILDIZ Esma,Topbas Murat,ozgur orhan,Arslan Mehmet Sociodemographic characteristics and clinical risk factors of Helicobacter pylori infection and antibiotic resistance in the Eastern Black Sea region of Turkey. (2020): 221 - 233. 10.5152/tjg.2020.18631
MLA	erkut murat,UZUN Doğan Yusuf,KAKLIKKAYA NESE,FİDAN Sami,YOĞUN Yaşar,COŞAR Arif Mansur,AKYILDIZ Esma,Topbas Murat,ozgur orhan,Arslan Mehmet Sociodemographic characteristics and clinical risk factors of Helicobacter pylori infection and antibiotic resistance in the Eastern Black Sea region of Turkey. , 2020, ss.221 - 233. 10.5152/tjg.2020.18631
AMA	erkut m,UZUN D,KAKLIKKAYA N,FİDAN S,YOĞUN Y,COŞAR A,AKYILDIZ E,Topbas M,ozgur o,Arslan M Sociodemographic characteristics and clinical risk factors of Helicobacter pylori infection and antibiotic resistance in the Eastern Black Sea region of Turkey. . 2020; 221 - 233. 10.5152/tjg.2020.18631
Vancouver	erkut m,UZUN D,KAKLIKKAYA N,FİDAN S,YOĞUN Y,COŞAR A,AKYILDIZ E,Topbas M,ozgur o,Arslan M Sociodemographic characteristics and clinical risk factors of Helicobacter pylori infection and antibiotic resistance in the Eastern Black Sea region of Turkey. . 2020; 221 - 233. 10.5152/tjg.2020.18631
IEEE	erkut m,UZUN D,KAKLIKKAYA N,FİDAN S,YOĞUN Y,COŞAR A,AKYILDIZ E,Topbas M,ozgur o,Arslan M "Sociodemographic characteristics and clinical risk factors of Helicobacter pylori infection and antibiotic resistance in the Eastern Black Sea region of Turkey." , ss.221 - 233, 2020. 10.5152/tjg.2020.18631
ISNAD	erkut, murat vd. "Sociodemographic characteristics and clinical risk factors of Helicobacter pylori infection and antibiotic resistance in the Eastern Black Sea region of Turkey". (2020), 221-233. https://doi.org/10.5152/tjg.2020.18631

APA	erkut m, UZUN D, KAKLIKKAYA N, FİDAN S, YOĞUN Y, COŞAR A, AKYILDIZ E, Topbas M, ozgur o, Arslan M (2020). Sociodemographic characteristics and clinical risk factors of Helicobacter pylori infection and antibiotic resistance in the Eastern Black Sea region of Turkey. Turkish Journal of Gastroenterology, 31(3), 221 - 233. 10.5152/tjg.2020.18631
Chicago	erkut murat,UZUN Doğan Yusuf,KAKLIKKAYA NESE,FİDAN Sami,YOĞUN Yaşar,COŞAR Arif Mansur,AKYILDIZ Esma,Topbas Murat,ozgur orhan,Arslan Mehmet Sociodemographic characteristics and clinical risk factors of Helicobacter pylori infection and antibiotic resistance in the Eastern Black Sea region of Turkey. Turkish Journal of Gastroenterology 31, no.3 (2020): 221 - 233. 10.5152/tjg.2020.18631
MLA	erkut murat,UZUN Doğan Yusuf,KAKLIKKAYA NESE,FİDAN Sami,YOĞUN Yaşar,COŞAR Arif Mansur,AKYILDIZ Esma,Topbas Murat,ozgur orhan,Arslan Mehmet Sociodemographic characteristics and clinical risk factors of Helicobacter pylori infection and antibiotic resistance in the Eastern Black Sea region of Turkey. Turkish Journal of Gastroenterology, vol.31, no.3, 2020, ss.221 - 233. 10.5152/tjg.2020.18631
AMA	erkut m,UZUN D,KAKLIKKAYA N,FİDAN S,YOĞUN Y,COŞAR A,AKYILDIZ E,Topbas M,ozgur o,Arslan M Sociodemographic characteristics and clinical risk factors of Helicobacter pylori infection and antibiotic resistance in the Eastern Black Sea region of Turkey. Turkish Journal of Gastroenterology. 2020; 31(3): 221 - 233. 10.5152/tjg.2020.18631
Vancouver	erkut m,UZUN D,KAKLIKKAYA N,FİDAN S,YOĞUN Y,COŞAR A,AKYILDIZ E,Topbas M,ozgur o,Arslan M Sociodemographic characteristics and clinical risk factors of Helicobacter pylori infection and antibiotic resistance in the Eastern Black Sea region of Turkey. Turkish Journal of Gastroenterology. 2020; 31(3): 221 - 233. 10.5152/tjg.2020.18631
IEEE	erkut m,UZUN D,KAKLIKKAYA N,FİDAN S,YOĞUN Y,COŞAR A,AKYILDIZ E,Topbas M,ozgur o,Arslan M "Sociodemographic characteristics and clinical risk factors of Helicobacter pylori infection and antibiotic resistance in the Eastern Black Sea region of Turkey." Turkish Journal of Gastroenterology, 31, ss.221 - 233, 2020. 10.5152/tjg.2020.18631
ISNAD	erkut, murat vd. "Sociodemographic characteristics and clinical risk factors of Helicobacter pylori infection and antibiotic resistance in the Eastern Black Sea region of Turkey". Turkish Journal of Gastroenterology 31/3 (2020), 221-233. https://doi.org/10.5152/tjg.2020.18631